8-K/A XBRL

8-K/A

Company: HALOZYME THERAPEUTICS, INC.
Filed: August 9, 2022
Period of Report: May 24, 2022
Accession Number: 0001159036-22-000051

View Document ↗ View on SEC.gov ↗